Abstract

Purpose: The purpose of this study was to determine HIV prevalence among participants admitted to the delivery room and recent birth attendants. Materials and Methods: This was a descriptive, cross-sectional, analytical study, with a prospective collection from February 1, 2018 to January 31, 2019 at fousseyni Daou Hospital in Kayes, Mali. Results: During our study period, we recorded 4269 deliveries. HIV-positive patients known before labour accounted for 0.21%. Four hundred and six participants received counselling/testing in the delivery room; of which 36 refused the test: 8.87% and 370 accepted or 91.13%. Thirteen patients tested positive or 3.51%. The 20 - 35 age group was the most represented at 76.92%. Positive patients tested received ARV treatment in the delivery room in 92.31% of cases; and 1 patient or 7.69% did not receive treatment for refusal. Vaginal delivery was the most common at 77%, with caesarean section 23%. Newborns had a good prognosis in their first weeks of life in 85%; fetal lethality was observed in 15% of newborns including 1 case of fresh stillbirth and 1 case of pediatric deaths for neonatal suffering. Conclusion: Counselling and voluntary HIV/AIDS testing during labour and immediate postpartum can detect many pregnant women who escape screening during antenatal consultations.

Highlights

  • AIDS is a state of viro-induced immune deficiency [1]

  • HIV-positive patients known before labour accounted for 0.21%

  • Counselling and voluntary HIV/AIDS testing during labour and immediate postpartum can detect many pregnant women who escape screening during antenatal consultations

Read more

Summary

Introduction

In 2010, 3.4 million infected people were children and more than 90% were infected vertically during pregnancy or breastfeeding. Mother-to-child transmission is one of the main modes of contamination [2]. This can be achieved in utero, per-partum, post partum and maternal breastfeeding [3]. There have been several methods of preventing mother-to-child transmission of HIV. Their evolution is linked to a better understanding of the risk factors for vertical HIV transmission, and to the implementation of numerous clinical trials and protocols focusing on the use of antiretrovirals

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call